Advisory: Give yourself extra time when travelling by car to Toronto General Hospital, Princess Margaret Cancer Centre, or Toronto Rehab University Centre. City of Toronto construction on University Ave. may cause delays.
At UHN, we strive to deliver Compassionate Care & Caring. Learn more about the services and supports that are available to you throughout your journey.
Our UHN programs and services are among the most advanced in the world. We have grouped our physicians,
staff, services and resources into 10 medical programs to meet the needs of our patients and help us make
the most of our resources.
At the heart of everything we do at UHN are our Healthcare Professionals. Refer a patient to one of our 12 medical programs. Learn more about the resources and opportunities available for professional growth.
University Health Network has grown to be one of the largest research and teaching hospital networks in Canada - pioneers in improving the lives of patients. Our long history of health professions education at Toronto General, Toronto Western, Princess Margaret and Toronto Rehab hospitals has consistently advanced the science of education.
University Health Network is a health care and medical research organization in
Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international
source for discovery, education and patient care.
Being touched by illness affects us in different ways. Many people want to give back to the community
and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one
of our experts for an interview. It's also the place to find UHN media policies and catch up on our news stories, videos, media releases,
podcasts and more.
Premier Kathleen Wynne visited Toronto Western Hospital on Tuesday to showcase an Ontario-Israel partnership that is bringing new technology to the province to treat neurological disorders, such as Parkinson's disease and essential tremor.
Accompanied by UHN CEO Dr. Peter Pisters and cardiologist Dr. Kenneth Melvin, the Premier was given a tour by neurosurgeon Dr. Andres Lozano of his Magnetic Resonance-guided Focused Ultrasound (MRgFUS) Lab.
The lab is benefiting from a $3 million Memorandum of Understanding, one of 44 agreements that were announced during Premier Wynne's mission to Israel and the West Bank last week and will position Ontario as a leader in focused ultrasound technology.
"This partnership is an exciting opportunity for Ontario to pursue new technology to help people suffering from neurological disorders," said Premier Wynne at a media availability following the tour.
In December 2012, Dr. Lozano and a team of co-investigators at Sunnybrook Health Sciences Centre were the first Canadian team to pioneer a procedure using MRgFUS to successfully treat patients with disabling tremors and the group published the world's first research paper on the subject.
This outpatient procedure is described as "scalpel-free surgery" since there is no incision. There is no general anesthetic required, the patient remains awake and alert during treatment, and can go home the next day.
Similar to focusing the heat of the sun through a magnifying glass, the technology allows investigators to focus ultrasound waves under MRI guidance through a patient's skull to reach an area located deep in the brain.
Once that area has been located, the 1,024 focused ultrasound waves are delivered to a focal target over 10 seconds to destroy the neurons that are responsible for the tremor.
Since no incision is made and no device is implanted in the brain, there is no risk of bleeding in the brain or infection once the surgery is complete, greatly limiting the side-effects of the procedure.
"This partnership will greatly help UHN become a world leading centre to advance the MRgFUS technology research and treatment," said Dr. Lozano.
"As we develop novel technologies and perform clinical trials in this field, we hope to develop new indications for MRgFUS including treatments for pain, psychiatric disorders,epilepsy and brain tumours which will not only help thousands of patients in Ontario, but throughout the world."